Vanguard Funds Are Normally Great Investments, but I'd Avoid This One Right Now NASDAQ · Markets 17m ago
AstraZeneca's Tezspire Shows Sustained Benefits In Phase 3 Esophagitis Trial NASDAQ · Markets 17m ago
Salesforce announces $5.66 billion deal for Braze, sending BRZE stock soaring 50% CNBC · Economy 19m ago
Another Rate Hike Is Expected Before the End of 2026. Here's Why It Might Have a Much Bigger Impact on the Markets This Time NASDAQ · Markets 23m ago
Viking Therapeutics Initiates Pivotal Phase 3 Trial: Here's Why Investors Have Reason for Optimism After a Disappointing Phase 2 NASDAQ · Markets 32m ago